Abstract:Background and objective: Artificial intelligence (AI) has several uses in the healthcare industry, some of which include healthcare management, medical forecasting, practical making of decisions, and diagnosis. AI technologies have reached human-like performance, but their use is limited since they are still largely viewed as opaque black boxes. This distrust remains the primary factor for their limited real application, particularly in healthcare. As a result, there is a need for interpretable predictors that provide better predictions and also explain their predictions. Methods: This study introduces "DeepXplainer", a new interpretable hybrid deep learning-based technique for detecting lung cancer and providing explanations of the predictions. This technique is based on a convolutional neural network and XGBoost. XGBoost is used for class label prediction after "DeepXplainer" has automatically learned the features of the input using its many convolutional layers. For providing explanations or explainability of the predictions, an explainable artificial intelligence method known as "SHAP" is implemented. Results: The open-source "Survey Lung Cancer" dataset was processed using this method. On multiple parameters, including accuracy, sensitivity, F1-score, etc., the proposed method outperformed the existing methods. The proposed method obtained an accuracy of 97.43%, a sensitivity of 98.71%, and an F1-score of 98.08. After the model has made predictions with this high degree of accuracy, each prediction is explained by implementing an explainable artificial intelligence method at both the local and global levels. Conclusions: A deep learning-based classification model for lung cancer is proposed with three primary components: one for feature learning, another for classification, and a third for providing explanations for the predictions made by the proposed hybrid (ConvXGB) model. The proposed "DeepXplainer" has been evaluated using a variety of metrics, and the results demonstrate that it outperforms the current benchmarks. Providing explanations for the predictions, the proposed approach may help doctors in detecting and treating lung cancer patients more effectively.

Identification of biological markers in cancer disease using explainable artificial intelligence

Discovering genetic biomarkers for targeted cancer therapeutics with eXplainable AI

Developing Anticancer Drug Response System Using Deep Learning System with Hybrid Genomic and Chemical Features

Precision Cancer Classification and Biomarker Identification from mRNA Gene Expression via Dimensionality Reduction and Explainable AI

Predicting drug activity against cancer through genomic profiles and SMILES

Cancer Metastasis Prediction and Genomic Biomarker Identification through Machine Learning and eXplainable Artificial Intelligence in Breast Cancer Research

maGENEgerZ: An Efficient Artificial Intelligence-Based Framework Can Extract More Expressed Genes and Biological Insights Underlying Breast Cancer Drug Response Mechanism

Explainable machine learning of the breast cancer staging for designing smart biomarker sensors

XAI-MethylMarker: Explainable AI approach for biomarker discovery for breast cancer subtype classification using methylation data

Peripheral Blood Mononuclear Cell derived Biomarker detection using eXplainable Artificial Intelligence (XAI) provides better diagnosis of Breast Cancer

Transfer learning based approach for lung and colon cancer detection using local binary pattern features and explainable artificial intelligence (AI) techniques

XGraphCDS: An explainable deep learning model for predicting drug sensitivity from gene pathways and chemical structures

DeepXplainer: An interpretable deep learning based approach for lung cancer detection using explainable artificial intelligence

Pan-Cancer Drug Sensitivity Prediction from Gene Expression using Deep Learning

Refining breast cancer biomarker discovery and drug targeting through an advanced data-driven approach

maGENEgerZ: An Efficient AI-Based Framework Can Extract More Expressed Genes and Biological Insights Underlying Breast Cancer Drug Response Mechanism

Breast Cancer Diagnosis: A Comprehensive Exploration of Explainable Artificial Intelligence (XAI) Techniques

Identification of Gene Expression in Different Stages of Breast Cancer with Machine Learning

Drug Response Prediction of Liver Cancer Cell Line Using Deep Learning

Bimodal gene expression in cancer patients provides interpretable biomarkers for drug sensitivity

Exploring Explainable AI Techniques for Improved Interpretability in Lung and Colon Cancer Classification